Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Reflect Scientific, Inc. (RSCF)
USD0.04
0.00 (-1.08%)
US OTC Healthcare Medical - Instruments & Supplies
Address
1266 South 1380 West 84058
Orem, UT, US
Orem, UT, US
CEO
Kim Boyce
Website
reflectscientific.com
IPO
2007-05-01
CIK 1103090 ISIN US75866F1012
Description
Reflect Scientific, Inc., through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra-low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as filtration and purification products, customized sample handling vials, electronic wiring assemblies, high temperature silicone, and graphite and vespel/graphite sealing components for use by original equipment manufacturers in the field of gas/liquid chromatography in the chemical analysis industries. In addition, the company offers solvent chillers and refrigerated transportation products; and UV detectors and vial products. It serves hospitals, diagnostic laboratories, pharmaceutical and biotech companies, universities, governments, and private sector research facilities, as well as cold chain management, chemical, and industrial companies. The company was founded in 1999 and is based in Orem, Utah.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.04
0.00 (-1.08%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
44.0K
Beta
1.75
Float Shares
40.03M
Free Float %
46.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +16.28% | +18.48% | +5.37% | +0.00% | +2.04% | -5.30% | +1.83% | +0.00% | -81.47% | -15.25% | -95.37% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.04
DCF (Unlevered)
0.03
-29.2%
DCF (Levered)
0.02
-41.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Quality scores
Altman Z-Score
-1.06
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-14.0% Q1'26: +6.8% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+20.0% ★ Q1'26: +14.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+15.3% Q1'26: +96.1% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+10.3% Q1'26: +13.9% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+33.4% ★ Q1'26: +28.4% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×0.43× ★ Q1'26: 0.24× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-01 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-149.9K
OE per share TTM
0.00
Owner's Yield
-3.62%
Maintenance CapEx ratio
6.82%
Maint CapEx / Avg PPE
6.3%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
1
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BRONCO (BARCLAYS CAYMAN) LIMITED | — | 0.00% | 3.12M | — | 3.12M | — | — | Utah. | 2011-04-06 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
5
Sells
0
Shares acquired
137.3K
Shares disposed
—
Cash buys
5.00
Cash sales
—
Net activity
+137,250
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-23 | BOYCE KIM | Officer | P-Purchase | A | Common Stock | 17,250 | 0.12 | 2.0K | 43,637,250 | — | ↗ |
| 2022-08-11 | BOYCE KIM | Officer | P-Purchase | A | Common Stock | 20,000 | 0.12 | 2.3K | 43,620,000 | — | ↗ |
| 2022-08-03 | BOYCE KIM | Officer | P-Purchase | A | Common Stock | 25,000 | 0.12 | 3.0K | 43,600,000 | — | ↗ |
| 2022-07-20 | BOYCE KIM | Officer | P-Purchase | A | Common Stock | 25,000 | 0.11 | 2.7K | 43,575,000 | — | ↗ |
| 2022-07-12 | BOYCE KIM | Officer | P-Purchase | A | Common Stock | 50,000 | 0.10 | 5.0K | 43,550,000 | — | ↗ |
| 2021-05-29 | Tait Thomas A | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 900,000 | — | ↗ |
| 2021-05-29 | Moon William G | Director | — | D | Common Stock | 0 | 0.00 | — | 1,100,000 | — | ↗ |
| 2021-05-29 | BOYCE KIM | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 43,500,000 | — | ↗ |
| 2019-12-30 | Tait Thomas A | Director / Officer | A-Award | A | Common Stock | 100,000 | 0.01 | 1.0K | 900,000 | — | ↗ |
| 2019-12-30 | Moon William G | Director | A-Award | A | Common Stock | 100,000 | 0.01 | 1.0K | 900,000 | — | ↗ |
| 2019-12-30 | MERRELL KEITH L | Officer | A-Award | A | Common Stock | 81,000 | 0.01 | 810.00 | 501,333 | — | ↗ |
| 2019-12-30 | BOYCE KIM | Officer | A-Award | A | Common Stock | 2,500,000 | 0.01 | 25.0K | 43,500,000 | — | ↗ |
| 2018-12-28 | Tait Thomas A | Director / Officer | A-Award | A | Common Stock | 100,000 | 0.01 | 1.0K | 800,000 | — | ↗ |
| 2018-12-28 | Moon William G | Director | A-Award | A | Common Stock | 100,000 | 0.01 | 1.0K | 800,000 | — | ↗ |
| 2018-12-28 | MERRELL KEITH L | Officer | A-Award | A | Common Stock | 81,000 | 0.01 | 810.00 | 420,333 | — | ↗ |
| 2018-12-28 | BOYCE KIM | Officer | A-Award | A | Common Stock | 1,000,000 | 0.01 | 10.0K | 41,000,000 | — | ↗ |
| 2017-12-29 | Tait Thomas A | Director / Officer | A-Award | A | Common Stock | 100,000 | 0.01 | 1.0K | 700,000 | — | ↗ |
| 2017-12-29 | Moon William G | Director | A-Award | A | Common Stock | 100,000 | 0.01 | 1.0K | 700,000 | — | ↗ |
| 2017-12-29 | MERRELL KEITH L | Officer | A-Award | A | Common Stock | 81,000 | 0.01 | 810.00 | 339,333 | — | ↗ |
| 2017-12-29 | BOYCE KIM | Officer | A-Award | A | Common Stock | 4,000,000 | 0.01 | 40.0K | 40,000,000 | — | ↗ |
| 2016-12-09 | Tait Thomas A | Director / Officer | A-Award | A | Common Stock | 100,000 | 0.01 | 1.0K | 600,000 | — | ↗ |
| 2016-12-09 | Moon William G | Director | A-Award | A | Common Stock | 100,000 | 0.01 | 1.0K | 600,000 | — | ↗ |
| 2016-12-09 | MERRELL KEITH L | Officer | A-Award | A | Common Stock | 81,000 | 0.01 | 810.00 | 258,333 | — | ↗ |
| 2016-06-03 | BOYCE KIM | Director / Officer / 10% Owner | A-Award | A | Common Stock | 3,356,750 | 0.01 | 33.6K | 36,000,000 | — | ↗ |
| 2015-12-28 | Tait Thomas A | Director / Officer | A-Award | A | Common Stock | 139,000 | 0.04 | 5.6K | 500,000 | — | ↗ |
| 2015-12-28 | Moon William G | Director | A-Award | A | Common Stock | 250,000 | 0.04 | 10.0K | 500,000 | — | ↗ |
| 2015-12-28 | MERRELL KEITH L | Officer | A-Award | A | Common Stock | 53,333 | 0.04 | 2.1K | 177,333 | — | ↗ |
| 2015-07-02 | BOYCE KIM | Director / Officer / 10% Owner | A-Award | A | Common Stock | 3,000,000 | 0.04 | 120.0K | 32,643,250 | — | ↗ |
| 2014-10-30 | MERRELL KEITH L | Officer | — | D | Common Stock | 0 | 0.00 | — | 124,000 | — | ↗ |
| 2014-10-30 | BOYCE KIM | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,600,000 | 0.00 | — | 29,643,250 | — | ↗ |
| 2013-12-30 | BOYCE KIM | Director / Officer / 10% Owner | A-Award | A | Common Stock | 3,975,000 | 0.00 | — | 28,043,250 | — | ↗ |
| 2011-05-06 | Tait Thomas A | Director / Officer | G-Gift | A | Common Stock | 200,000 | 0.00 | — | 361,000 | — | ↗ |
| 2011-05-06 | Moon William G | Director | G-Gift | A | Common Stock | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2011-05-06 | BOYCE KIM | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 650,000 | 0.00 | — | 24,068,250 | — | ↗ |
| 2011-04-15 | Moon William G | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2011-04-04 | BOYCE KIM | Director / Officer / 10% Owner | J-Other | A | Common Stock | 7,800,000 | 0.00 | — | 24,718,250 | — | ↗ |
| 2008-02-05 | BOYCE KIM | Director / Officer / 10% Owner | J-Other | D | Common Stock | 1,000,000 | 0.00 | — | 16,918,250 | — | ↗ |
| 2007-12-31 | Tait Thomas A | Director / Officer | A-Award | A | Option | 200,000 | 1.20 | 240.0K | 200,000 | — | ↗ |
| 2007-12-31 | BOYCE KIM | Director / Officer / 10% Owner | A-Award | A | Options | 4,800,000 | 1.32 | 6.34M | 4,800,000 | — | ↗ |
| 2007-10-01 | Strate David Scott | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2007-06-20 | BOYCE KIM | Director / Officer | J-Other | D | Common Stock | 820,000 | 41,000.00 | 33.62B | 17,918,250 | — | ↗ |
| 2006-09-13 | Morrison Craig | Director | A-Award | A | Common stock | 10,000 | 0.98 | 9.8K | 110,000 | — | ↗ |
| 2006-09-13 | Cooksy Kevin | Officer | A-Award | A | Common stock | 15,000 | 0.98 | 14.7K | 40,000 | — | ↗ |
| 2006-08-29 | Tait Thomas A | Director / Officer | A-Award | A | Common Stock | 75,000 | 0.95 | 71.3K | 161,000 | — | ↗ |
| 2006-07-28 | Tait Thomas A | Director / Officer | P-Purchase | A | Common stock | 25,000 | 1.00 | 25.0K | 86,000 | — | ↗ |
| 2006-07-28 | BOYCE KIM | Director / Officer | P-Purchase | A | Common Stock | 15,000 | 1.00 | 15.0K | 18,738,250 | — | ↗ |
| 2006-05-26 | Tait Thomas A | Director / Officer | P-Purchase | A | Reflect Scientific Inc | 2,000 | 1.39 | 2.8K | 61,000 | — | ↗ |
| 2006-04-25 | Tait Thomas A | Director / Officer | P-Purchase | A | Common Stock | 3,000 | 1.50 | 4.5K | 59,000 | — | ↗ |
| 2006-04-19 | Tait Thomas A | Director / Officer | P-Purchase | A | Common Stock | 3,000 | 1.60 | 4.8K | 56,000 | — | ↗ |
| 2006-04-13 | Tait Thomas A | Director / Officer | P-Purchase | A | Common Stock | 3,000 | 1.40 | 4.2K | 53,000 | — | ↗ |
| 2005-05-11 | Morrison Craig | Director | — | D | Common stock | 0 | 0.00 | — | 100,000 | — | ↗ |
| 2005-05-11 | Cooksy Kevin | Officer | — | D | Common stock | 0 | 0.00 | — | 25,000 | — | ↗ |
| 2005-05-06 | Tait Thomas A | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 50,000 | — | ↗ |
| 2003-12-31 | BOYCE KIM | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 18,723,250 | — | ↗ |
Executive team
Top executives
EBIT / Employee
23.8K
Shares Outstanding
85.66M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kim Boyce | Founder, Chairman, Chief Executive Officer, Chief Financial Officer & President | 102.2K | male |
| William Grant Moon | Vice President of Engineering & Director | 48.0K | male |
| Thomas A. Tait | Vice President, Secretary & Director | 14.4K | male |
| Craig W. Morrison | Chairman of Technical Advisory Board & Technical Advisor | — | — |
| Eric Pierson | Managing Director of Miralogix | — | male |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RSCF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
